Previous 10 | Next 10 |
EWING, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2019 London Healthcare Conference on Wednesday November 20, 2019, at 11:20 am (GMT) / 6:20 am (EST) i...
The following slide deck was published by Antares Pharma, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Antares Pharma, Inc. (ATRS) Q3 2019 Earnings Conference Call November 5, 2019 8:30 AM ET Company Participants Jack Howarth – Vice President of Corporate Affairs Bob Apple – President and Chief Executive Officer Fred Powell – Executive Vice President and Chief...
Image source: The Motley Fool. Antares Pharma Inc (NASDAQ: ATRS) Q3 2019 Earnings Call Nov 5, 2019 , 8:30 a.m. ET Operator Continue reading
FlexShopper (NASDAQ: FPAY ) +36% on Q3 results . More news on: FlexShopper, Inc., EverQuote, Inc., Inovio Pharmaceuticals, Inc., Stocks on the move, Read more ...
Antares Pharma (NASDAQ: ATRS ) Q3 results : More news on: Antares Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Antares Pharma (NASDAQ: ATRS ): Q3 GAAP EPS of $0.01 beats by $0.03 . Revenue of $34.3M (+91.9% Y/Y) beats by $7.41M . Press Release More news on: Antares Pharma, Inc., Earnings news and commentary, Healthcare stocks news,
Record Quarterly Revenue of $34.3 Million – Earnings Per Share of $0.01 The Company Increases Full Year 2019 Revenue Guidance to a Range of $115.0 to $120.0 Million EWING, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company...
EWING, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “Company”) today announced that it has received the final payment of $2.5 million from Ferring Pharmaceuticals (“Ferring”) in connection with the previo...
EWING, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2019 financial results and recent operating progress before the market opens on Tuesday, November 5, 2019. Management will host a webcast and conference...
News, Short Squeeze, Breakout and More Instantly...
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire SAN DIEGO , May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced that the waiting period unde...
Antares Pharma Inc shares ( NASDAQ: ATRS ) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement The deal translates to $5.60 per share for Antares Pharma shareholders that...